Clinical trial
Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS
NCT00428311 · Hospital Universitario Ramon y Cajal, Other · Completed
Key facts
| NCT number | NCT00428311 |
|---|---|
| Title | Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS |
| Official title | The Cardiovascular Risk Profile Associated With The Polycystic Ovary Syndrome And With Ovulatory Hyperandrogenism, And Its Changes During Treatment With Metformin Or Oral Contraceptives |
| Lead sponsor | Hospital Universitario Ramon y Cajal, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Polycystic Ovary Syndrome |
| Intervention type | Drug |
| Interventions | Metformin, Ethynyl-estradiol plus cyproterone acetate |
| Enrollment | 50 |
| Start date | Apr 1, 2004 |
| Completion | Oct 1, 2006 |
| First posted | Jan 30, 2007 |
| Last update posted | Jan 31, 2007 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: